ClinicalTrials.Veeva

Menu

Catechin Containing Mask for the Prevention of Influenza Infection

U

University of Shizuoka

Status

Completed

Conditions

Influenza Infection

Treatments

Dietary Supplement: tea catechin extracts

Study type

Interventional

Funder types

Other

Identifiers

NCT00812448
20-24
CT2009001

Details and patient eligibility

About

The purpose of this study is to evaluate the effects of catechin extracts containing mask on prevention of influenza infection.

Full description

Catechins are the major components of tea flavonoids and are reported to possess physiological activities such as antiviral effects. Recent in-vitro experimental studies have revealed that tea catechin extracts possess the effects on the prevention of influenza infection. However, a limited number of studies have been conducted on the clinical effects. Based on these backgrounds, we designed a prospective randomized controlled study to evaluate the effects of tea catechin extracts containing mask on the prevention of influenza infection.

Enrollment

180 patients

Sex

All

Ages

20 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Possible to wearing mask for three months
  • Possible to fill out a questionnaire personally
  • Obtained written informed consent before participation

Exclusion criteria

  • Possessing some infectious diseases in need of therapy
  • Possessing tea or catechin allergy
  • diagnosed as inadequate for other reasons to participate the study by principal investigator

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

180 participants in 1 patient group

tea catechin extracts containing mask
Experimental group
Description:
wearing the tea catechin extracts containing mask
Treatment:
Dietary Supplement: tea catechin extracts

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems